GAITHERSBURG, Md., Jan. 7, 2026 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it will participate in the 44 Annual J.P. Morgan Healthcare Conference. Conference Details: Novavax, Inc. (Nasdaq: NVAX) tackles some of the world's most pressing health challenges with its scientific expertise in vaccines and its proven technology platform, including protein-based nanoparticles and its Matrix- M adjuvant. The Company's growth strategy seeks to optimize its existing partnerships and expand acce ...